ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 47 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $102,000 | -7.3% | 104,000 | -6.3% | 0.00% | 0.0% |
| Q1 2018 | $110,000 | -45.8% | 111,000 | -47.4% | 0.00% | 0.0% |
| Q1 2017 | $203,000 | -4.7% | 211,000 | -0.5% | 0.00% | 0.0% |
| Q4 2016 | $213,000 | +36.5% | 212,000 | +26.2% | 0.00% | 0.0% |
| Q3 2016 | $156,000 | +32.2% | 168,000 | 0.0% | 0.00% | 0.0% |
| Q2 2016 | $118,000 | -41.6% | 168,000 | -24.7% | 0.00% | 0.0% |
| Q1 2016 | $202,000 | – | 223,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alken Asset Management Ltd | 850,000 | $848,000 | 3.53% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 34,448,000 | $35,346,000 | 1.72% |
| Sonora Investment Management, LLC | 9,376,000 | $9,408,000 | 1.12% |
| CSS LLC/IL | 7,500,000 | $7,639,000 | 0.60% |
| IRON Financial LLC | 490,000 | $498,000 | 0.31% |
| MACKAY SHIELDS LLC | 32,910,000 | $33,383,000 | 0.31% |
| RWC Asset Management LLP | 4,550,000 | $4,642,000 | 0.24% |
| Opti Capital Management, LP | 1,000 | $1,024,000 | 0.21% |
| PALISADE CAPITAL MANAGEMENT, LP | 4,871,000 | $4,956,000 | 0.18% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 5,283,000 | $5,301,000 | 0.12% |